Skip to content

Clinical trials

Phase 2 Hypoxia trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypoxia Phase: Phase 2 Country / region: United States Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20072
20091
20121
20153
20162
20201
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Terminated4
Recruiting2
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Global Blood Therapeutics2
Rain Oncology Inc2
Bastiaan Driehuys1
IRulya Therapeutics Inc.1
Intermountain Health Care, Inc.1
Jon Rittenberger, MD1
Mayo Clinic1
Naval Health Research Center1
Roger Alvarez1
University of Pennsylvania1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypoxia13
Carcinoma, Squamous Cell2
Idiopathic Pulmonary Fibrosis2
Anemia1
Anemia, Iron-Deficiency1
Brain Death1
Brain Injuries1
Brain Injuries, Traumatic1
COVID-191
Carcinoma, Non-Small-Cell Lung1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.